Government ‘working towards’ enabling hub-and-spoke dispensing in 2025 The proposed legislation will enable hub-and-spoke dispensing between different legal entities, changing the current rules that only permit this model of dispensing between pharmacy locations that belong to the same legal entity.…
Welsh community pharmacies to receive 6% funding increase, government confirms The government says that £9.9m funding increase is aimed to address “immediate pressures” and contribute towards realising its long-term reform plans.…
Pharmacists recognised in New Year Honours List 2025 RPS member Alan Kurtz, RPS Fellow Laura McIver and Michelle Riddalls, chief executive of the PAGB, have been recognised for their services to pharmacy.…
Approval of new NHS drugs results in population health ‘trade-offs’, study results suggest Study authors concluded that the use of new drugs on the NHS resulted in an additional cost of more than £75bn between 2000 and 2020.…
Pharmacy contract negotiations to start in new year, says health secretary Speaking at an evidence session held by the Health and Social Care Committee, Wes Streeting said his main focus was on “stabilising the system”.…
Government advises ICBs set up local plans to address PERT supply shortages The supply shortage impacts three pancreatic enzyme replacement therapy products: Creon (Viatris) 10,000 and 25,000 capsules, Nutrizym 22 (Zentiva) capsules and Pancrex V (Essential Pharma) capsules and powder.…
Pharmacy First treatment options should be broadened to support antimicrobial stewardship, says CCA The Company Chemists’ Association says widening treatment options for conditions under the Pharmacy First service would “ensure antibiotics are only provided when absolutely required”.…
NHS England delays mandatory multi-sector foundation training rotations Cross-sector rotations had been due to start for 2026/2027 pharmacy foundation trainees, but they will now not be mandatory until the following year.…
NICE recommends vadadustat for anaemia during dialysis for chronic kidney disease Draft guidance says that vadadustat is a cost-effective oral alternative to erythropoiesis stimulating agents for the treatment of anaemia in patients with chronic kidney disease receiving dialysis.…
Ban on puberty blockers in the UK made indefinite, government says Independent expert advice provided by the Commission on Human Medicines has urged that the ban continue while progress is made towards safeguarding children and young people.…